Takeshi Kawarabayashi Selected Research

Takeshi Kawarabayashi Research Topics

Disease

24	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 02/2002
7	Tauopathies 01/2023 - 06/2006
7	Amyloidosis 01/2023 - 04/2004
4	Parkinson Disease (Parkinson's Disease) 11/2010 - 08/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 11/2009
3	Memory Disorders (Memory Loss) 03/2011 - 03/2002
3	Synucleinopathies 11/2009 - 08/2007
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 03/2019 - 11/2010
2	Polyneuropathies (Polyneuropathy) 03/2019 - 11/2010
2	Multiple System Atrophy 01/2019 - 11/2010
2	Down Syndrome (Down's Syndrome) 08/2007 - 08/2004
1	Body Weight (Weight, Body) 01/2023
1	Atherosclerosis 01/2023
1	Hypophysitis 09/2021
1	Infarction (Infarctions) 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Dementia (Dementias) 01/2020
1	Quadriplegia (Spastic Quadriplegia) 03/2019
1	Respiratory Insufficiency (Respiratory Failure) 03/2019
1	Muscle Weakness 03/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Hereditary Myopathy with Early Respiratory Failure 05/2015
1	Nervous System Diseases (Neurological Disorders) 11/2010
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2010
1	Lymphoma (Lymphomas) 01/2009
1	Necrosis 01/2009
1	Osteomyelitis 01/2009
1	Tetanus 01/2009
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2008
1	Frontotemporal Dementia (Semantic Dementia) 02/2005

Drug/Important Bio-Agent (IBA)

11	Amyloid (Amyloid Fibrils)IBA 01/2023 - 03/2002
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2002
4	Amyloid beta-PeptidesIBA 05/2008 - 04/2004
3	alpha-SynucleinIBA 11/2009 - 08/2007
3	Presenilin-1IBA 08/2007 - 03/2002
2	Threonine (L-Threonine)FDA Link 01/2023 - 01/2020
2	LipidsIBA 01/2022 - 04/2004
2	SteroidsIBA 09/2021 - 03/2019
2	Indicators and Reagents (Reagents)IBA 12/2020 - 11/2009
2	Lipoproteins (Lipoprotein)IBA 06/2011 - 08/2004
2	AntibodiesIBA 07/2008 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 10/2002 - 03/2002
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Apolipoprotein E2IBA 01/2023
1	Apolipoprotein E4IBA 01/2023
1	Apolipoprotein E3IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	HDL CholesterolIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	Contrast MediaIBA 09/2021
1	EnzymesIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2019
1	SynucleinsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 05/2015
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 04/2011
1	Apolipoproteins D (Apo D)IBA 04/2011
1	Coloring Agents (Dyes)IBA 11/2010
1	LatexIBA 11/2010
1	Cystatin CIBA 11/2010
1	Metronidazole (Metric)FDA LinkGeneric 01/2009
1	Prealbumin (Transthyretin)IBA 01/2009
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2009
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 08/2008
1	Levodopa (L Dopa)FDA LinkGeneric 08/2008
1	Scavenger Receptors (Scavenger Receptor)IBA 06/2008
1	Genetic Markers (Genetic Marker)IBA 05/2008
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2008
1	Peptide Initiation Factors (Initiation Factor)IBA 06/2006
1	Prion ProteinsIBA 02/2005
1	ApolipoproteinsIBA 04/2004
1	Cholinergic Agents (Cholinergics)IBA 04/2004
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2004
1	Monoclonal AntibodiesIBA 08/2002
1	Flavin-Adenine Dinucleotide (FAD)IBA 03/2002
1	Detergents (Detergent)IBA 03/2002
1	CholesterolIBA 02/2002

Therapy/Procedure

5	Therapeutics 09/2021 - 01/2009
1	Plasma Exchange 03/2019
1	Radiotherapy 01/2009
1	Injections 01/2009